CliffBio
small molecule

TETRACYCLINE HYDROCHLORIDE

TETRACYCLINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyNovitium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameTETRACYCLINE HYDROCHLORIDE
Active ingredientTETRACYCLINE HYDROCHLORIDE
Strength250MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2020
Marketing statusRX

More from Novitium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.